The Global Resource For Connecting Buyers and Sellers

Evofem Biosciences Announces First Patient Enrolled in Phase 2b/3 STI Trial of Amphora® and Expects Phase 3 Contraceptive Clinical Trial Data First Quarter 2019

SAN DIEGO, Jan. 23, 2018 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM), a clinical-stage specialty biopharmaceutical company focused on the development and commercialization of women’s healthcare products, today announced enrollment of the first patient in a Phase 2b/3 clinical…